+ HEALTH Aims Intramuscular fat (IMF) is increasingly recognized as a marker of ectopic adiposity and adverse cardiome…+ HEALTH Periapical lesions are challenging to detect on intraoral radiographs because of anatomical superimposition a…± HEALTH Ultrasound imaging is an indispensable diagnostic tool, yet its profound reliance on operator expertise inher…+ HEALTH Objectives We adapted the individualized polysocial risk score (iPsRS), a machine learning model originally d…± HEALTH Melioidosis is a life-threatening infectious disease caused by Burkholderia pseudomallei ( Bp ). Rapid diagno…+ HEALTH Classification is a core machine learning task, and ensemble voting methods are widely used to improve predic…+ CLIMATE Microplastic (MP) pollution poses escalating environmental risks, demanding efficient and reproducible tools…± HEALTH Medicinal chemistry sits at the center of modern drug discovery, yet translating molecular designs into appro…
TruaceTracing the truth around AIWednesday, August 26, 2026
Subscribe
TRV-2026-0047Version 1 · Certified

Written 2026-07-12 20:50:18 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0047
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-07-12T20:50:18.089538Z
status: published
lens: p_space
sector: health
headline: Evolut r transcatheter aortic valve: FDA injury report involving AI
dek: The FDA received a injury report involving Evolut r transcatheter aortic valve, made by Medtronic mexico s. de r.l. de cv. It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure.
gain_reading: (none)
problem_reading: An FDA adverse-event report linked Evolut r transcatheter aortic valve to an AI-related injury; the report requires investigation and does not by itself establish causality.
limitation: FDA adverse-event reports can be incomplete, duplicated, or unverified and do not establish that a device caused the reported outcome.
tag: Evidence-backed problem
key_points: Device: Evolut r transcatheter aortic valve; manufacturer: Medtronic mexico s. de r.l. de cv. | FDA report type: Injury. | An adverse-event report is a safety signal, not proof that the device caused the event.
rundown: It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure.

The report is part of FDA’s MAUDE surveillance data. It should be read as a signal for follow-up, not a clinical conclusion or a verified incidence rate.
sources:
- government | FDA MAUDE report 24706346 | https://api.fda.gov/device/event.json?search=mdr_report_key%3A%2224706346%22&sort=date_received%3Adesc&limit=1 | 2026-03-26
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
85ef2873895dc0fd8935816a596bb55305af1aaed6b77e81db7c4726f5ef2660
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0047 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.